Friday, June 22, 2012

Stop Press: FDA confirms for 8th Annual Bioassays and Bioanalytical Method Development

Your job – and your customers’ lives – depends on your ability to design safe and non-immunogenic biomolecules. The best way for you to meet regulatory expectations and company deadlines is through expert insight straight from the source.

The 8th Annual Bioassays and Bioanalytical Method Development event is pleased to invite you to get your questions answered by one of the FDA’s top bioassay experts. Make sure to register today so you can see this exclusive information:

"Anticipating and Assessing the Immunogenicity of Biologics - A Scientific and Regulatory Perspective" presented by Zuben Sauna, PhD, Principal Investigator, Department of Hematology, CBER, FDA

For more information on this presentation and the rest of the event, download the agenda.

The 8th annual Bioassays and Bioanalytical Method Development conference will take place October 1-3, 2012 in Berkley, California. As a member of this LinkedIn group, when you register to join us today and mention code XP1768BLOG, you’ll save 15% off the standard rate! If you have any questions, feel free to email Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment